Profound Medical Corp Stock Toronto S.E.
Equities
PRN
CA74319B1067
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- CAD | - |
|
Sales 2024 * | 15.49M 11.37M | Sales 2025 * | 41.52M 30.47M | Capitalization | 306M 225M |
---|---|---|---|---|---|
Net income 2024 * | -40M -29.35M | Net income 2025 * | -31M -22.75M | EV / Sales 2024 * | 19.8 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 7.38 x |
P/E ratio 2024 * |
-7.65
x | P/E ratio 2025 * |
-8.67
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.31% |
Latest transcript on Profound Medical Corp
Managers | Title | Age | Since |
---|---|---|---|
Arun Menawat
CEO | Chief Executive Officer | 69 | 15-06-03 |
Rashed Dewan
DFI | Director of Finance/CFO | 56 | 15-06-30 |
Mathieu Burtnyk
COO | Chief Operating Officer | 42 | 11-07-06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Arthur Rosenthal
BRD | Director/Board Member | 77 | 18-06-13 |
Director/Board Member | 67 | 18-06-13 | |
Cynthia Lavoie
BRD | Director/Board Member | - | 21-03-02 |
1st Jan change | Capi. | |
---|---|---|
+2.24% | 205B | |
+6.45% | 179B | |
+31.46% | 158B | |
+33.00% | 113B | |
+4.87% | 64.93B | |
+21.77% | 56.51B | |
-2.92% | 46.36B | |
-5.91% | 37.07B | |
+3.39% | 36.12B |
- Stock Market
- Equities
- PRN Stock
- PRN Stock